Data as of Apr 17
| -0.27 / -3.18%|
The 7 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 20.00, with a high estimate of 33.00 and a low estimate of 10.00. The median estimate represents a +142.72% increase from the last price of 8.24.
The current consensus among 9 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.